Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink
Kayla E. Hanson(Marshfield Clinic), Huong Q. McLean(Marshfield Clinic), Holly C. Groom(Kaiser Permanente Center for Health Research), Lina S. Sy(Kaiser Permanente), Nicola P. Klein, Matthew F. Daley(Kaiser Permanente), Edward A. Belongia(Marshfield Clinic), Lakshmi Panagiotakopoulos(Centers for Disease Control and Prevention), Eric Weintraub, Mona Marin(National Center for Immunization and Respiratory Diseases), Malini B. DeSilva(HealthPartners), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute)
Cited by 13
Related Papers
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
|Science|2009|2.5k
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
|The Lancet Infectious Diseases|2011|1.8k
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661